Skip to main content
Top
Published in: CEN Case Reports 2/2017

01-11-2017 | Case report

Nephrocalcinosis in a young male with anorexia nervosa

Authors: Nicholas Chadi, Simon Carter, Robert P. Y. Loung, Michelle Gould, Katherine Hick

Published in: CEN Case Reports | Issue 2/2017

Login to get access

Abstract

Nephrocalcinosis (NC) has been described as a long-term complication of anorexia nervosa (AN). This is the first report of this complication in an adolescent male patient. We describe the case of a 12-year-old male with AN who presented with acute food restriction and excessive exercising leading to three inpatient admissions. The patient experienced an isolated episode of dysuria and hematuria while on calcium and vitamin D supplementation. Investigations revealed hypophosphatemia, hypercalciuria and mild NC. Follow-up confirmed the presence of NC and possible nephrolithiasis (NL). We discuss the pathophysiology and risk factors of NC and NL in the context of an early presentation of AN. We suggest fluid intake should be liberalized under observation and calcium and vitamin D supplementation should be initiated with caution in patients presenting with AN and risk factors for NC and NL.
Literature
1.
go back to reference Bouquegneau A, Dubois BE, Krzesinski JM, Delanaye P. Anorexia nervosa and the kidney. Am J Kidney Dis. 2012;60(2):299–307.CrossRef Bouquegneau A, Dubois BE, Krzesinski JM, Delanaye P. Anorexia nervosa and the kidney. Am J Kidney Dis. 2012;60(2):299–307.CrossRef
2.
go back to reference Stheneur C, Bergeron S, Lapeyraque AL. Renal complications in anorexia nervosa. Eat Weight Disord EWD. 2014;19(4):455–60.CrossRef Stheneur C, Bergeron S, Lapeyraque AL. Renal complications in anorexia nervosa. Eat Weight Disord EWD. 2014;19(4):455–60.CrossRef
3.
go back to reference Leaf DE, Bukberg PR, Goldfarb DS. Laxative abuse, eating disorders, and kidney stones: a case report and review of the literature. Am J Kidney Dis. 2012;60(2):295–8.CrossRef Leaf DE, Bukberg PR, Goldfarb DS. Laxative abuse, eating disorders, and kidney stones: a case report and review of the literature. Am J Kidney Dis. 2012;60(2):295–8.CrossRef
4.
go back to reference Herzog W, Deter HC, Fiehn W, Petzold E. Medical findings and predictors of long-term physical outcome in anorexia nervosa: a prospective, 12-year follow-up study. Psychol Med. 1997;27(2):269–79.CrossRef Herzog W, Deter HC, Fiehn W, Petzold E. Medical findings and predictors of long-term physical outcome in anorexia nervosa: a prospective, 12-year follow-up study. Psychol Med. 1997;27(2):269–79.CrossRef
5.
go back to reference Sharp CW, Freeman CP. The medical complications of anorexia nervosa. Br J Psychiatry J Mental Sci. 1993;162:452–62.CrossRef Sharp CW, Freeman CP. The medical complications of anorexia nervosa. Br J Psychiatry J Mental Sci. 1993;162:452–62.CrossRef
6.
go back to reference Lim AK, Hooke DH, Kerr PG. Anorexia nervosa and senna misuse: nephrocalcinosis, digital clubbing and hypertrophic osteoarthropathy. Med J Aust. 2008;188(2):121–2.PubMed Lim AK, Hooke DH, Kerr PG. Anorexia nervosa and senna misuse: nephrocalcinosis, digital clubbing and hypertrophic osteoarthropathy. Med J Aust. 2008;188(2):121–2.PubMed
7.
go back to reference Tran HA. Severe renal failure and nephrocalcinosis in anorexia nervosa. Med J Aust. 2006;184(1):46 (author reply 46). Tran HA. Severe renal failure and nephrocalcinosis in anorexia nervosa. Med J Aust. 2006;184(1):46 (author reply 46).
9.
go back to reference Schlingmann KP, Kaufmann M, Weber S, Irwin A, Goos C, John U, Misselwitz J, Klaus G, Kuwertz-Broking E, Fehrenbach H, Wingen AM, Guran T, Hoenderop JG, Bindels RJ, Prosser DE, Jones G, Konrad M. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med. 2011;365(5):410–21. doi:10.1056/NEJMoa1103864.CrossRefPubMed Schlingmann KP, Kaufmann M, Weber S, Irwin A, Goos C, John U, Misselwitz J, Klaus G, Kuwertz-Broking E, Fehrenbach H, Wingen AM, Guran T, Hoenderop JG, Bindels RJ, Prosser DE, Jones G, Konrad M. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med. 2011;365(5):410–21. doi:10.​1056/​NEJMoa1103864.CrossRefPubMed
10.
go back to reference Abdel-Rahman EM, Moorthy AV. End-stage renal disease (ESRD) in patients with eating disorders. Clin Nephrol. 1997;47(2):106–11.PubMed Abdel-Rahman EM, Moorthy AV. End-stage renal disease (ESRD) in patients with eating disorders. Clin Nephrol. 1997;47(2):106–11.PubMed
11.
go back to reference Arimura Y, Tanaka H, Yoshida T, Shinozaki M, Yanagida T, Ando T, Hirakata H, Fujishima M. Anorexia nervosa: an important cause of chronic tubulointerstitial nephropathy. Nephrol Dial Transpl Off Publ Eur Dial Transpl Assoc Eur Renal Assoc. 1999;14(4):957–9. Arimura Y, Tanaka H, Yoshida T, Shinozaki M, Yanagida T, Ando T, Hirakata H, Fujishima M. Anorexia nervosa: an important cause of chronic tubulointerstitial nephropathy. Nephrol Dial Transpl Off Publ Eur Dial Transpl Assoc Eur Renal Assoc. 1999;14(4):957–9.
12.
go back to reference Brotman AW, Stern TA, Brotman DL. Renal disease and dysfunction in two patients with anorexia nervosa. J Clin Psychiatry. 1986;47(8):433–4.PubMed Brotman AW, Stern TA, Brotman DL. Renal disease and dysfunction in two patients with anorexia nervosa. J Clin Psychiatry. 1986;47(8):433–4.PubMed
13.
go back to reference Takakura S, Nozaki T, Nomura Y, Koreeda C, Urabe H, Kawai K, Takii M, Kubo C. Factors related to renal dysfunction in patients with anorexia nervosa. Eat Weight Disord EWD. 2006;11(2):73–7.CrossRef Takakura S, Nozaki T, Nomura Y, Koreeda C, Urabe H, Kawai K, Takii M, Kubo C. Factors related to renal dysfunction in patients with anorexia nervosa. Eat Weight Disord EWD. 2006;11(2):73–7.CrossRef
14.
go back to reference Birmingham CL, Puddicombe D, Hlynsky J. Hypomagnesemia during refeeding in anorexia nervosa. Eat Weight Disord EWD. 2004;9(3):236–7.CrossRef Birmingham CL, Puddicombe D, Hlynsky J. Hypomagnesemia during refeeding in anorexia nervosa. Eat Weight Disord EWD. 2004;9(3):236–7.CrossRef
Metadata
Title
Nephrocalcinosis in a young male with anorexia nervosa
Authors
Nicholas Chadi
Simon Carter
Robert P. Y. Loung
Michelle Gould
Katherine Hick
Publication date
01-11-2017
Publisher
Springer Singapore
Published in
CEN Case Reports / Issue 2/2017
Electronic ISSN: 2192-4449
DOI
https://doi.org/10.1007/s13730-017-0267-0

Other articles of this Issue 2/2017

CEN Case Reports 2/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine